Contact SCGE




SCGE Consortium Home   |  About SCGE Toolkit   |  Contact Us   |  Citing the Toolkit   |  License  
ExperimentA novel human T cell platform to define biological adverse effects of genome editing
Experiment ConditionPDCD1_site_05
Assay Description: Calculated editing efficiency by targeted amplicon deep sequencing
Tissue Measured:
Measurement Type:Editing Efficiency
Record ID15000000500

EditorSpCas9
Delivery SystemP3 Nucleofection Kit
Delivery System SubtypeCommercial Reagent
GuidePDCD1_site_05
Vector

Model SpeciesHuman
Model NameCD4/CD8 Human Primary T cell

Application Methodnucleofection
Application Site
Dosage75 pmol Cas9 protein; 3-fold molar excess of sgRNA
Injection Frequency
Injection Rate
Injection Volume
Days post injection
Editor Formatribonucleoprotein (RNP)
Antidote Id
Antidote Description

Measured Values
Samples Size: 3
 
Replicate Result (Editing Efficiency)
Measurement Units: % of reads
Mean 59.50 
1 60.772478280590306 
2 58.8948528706987 
3 58.8316954663354 
  

Title Description File Download SCGE ID
Tsai_T Cell Transfection Protocol Procedure for T cell transfection. Tsai_T_cell_transfection.pdf 21000000006

Publication Title
CHANGE-seq reveals genetic and epigenetic effects on CRISPR-Cas9 genome-wide activity. NCBI